BioXcel Therapeutics (BTAI) Operating Leases (2019 - 2024)
BioXcel Therapeutics (BTAI) recorded quarterly Operating Leases of $65000.0 in Q4 2024, down 59.63% quarter-over-quarter from $161000.0 in Q3 2024, and down 85.23% on a YoY basis from $440000.0 in Q1 2024.
BioXcel Therapeutics (BTAI) Operating Leases (2019 - 2024) Analysis & Trends
BioXcel Therapeutics' Operating Leases history runs 6 years deep, the most recent figure standing at $65000.0 for Q4 2024.
- In Q4 2024, Operating Leases fell 85.23% year-over-year to $65000.0; the TTM figure through Dec 2024 stood at $65000.0 (down 85.23% YoY), while the FY2024 annual figure was $65000.0, down 85.23% from the prior year.
- Operating Leases was $65000.0 for Q4 2024 at BioXcel Therapeutics, down from $161000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $1.5 million in Q3 2020 to a low of $65000.0 in Q4 2024.
- Historically, Operating Leases has averaged $817650.0 across 5 years, with a median of $887500.0 in 2020.
- The sharpest annual moves came in 2021 and 2024: Operating Leases jumped 38.37% in 2021, then tumbled 85.23% in 2024.
- A 5-year view of Operating Leases shows it stood at $1.4 million in 2020, then declined by 20.96% to $1.1 million in 2021, then fell by 28.87% to $786000.0 in 2022, then tumbled by 44.02% to $440000.0 in 2023, then sank by 85.23% to $65000.0 in 2024.
- The last three Operating Leases figures came in at $65000.0 (Q4 2024), $161000.0 (Q3 2024), and $256000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 65,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Mar 31, 2024 | 350,000.00 |
| Dec 31, 2023 | 440,000.00 |
| Sep 30, 2023 | 529,000.00 |
| Jun 30, 2023 | 617,000.00 |
| Mar 31, 2023 | 703,000.00 |
| Dec 31, 2022 | 786,000.00 |
| Sep 30, 2022 | 868,000.00 |
| Jun 30, 2022 | 949,000.00 |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 1.26 Mn |
| Mar 31, 2021 | 1.33 Mn |
| Dec 31, 2020 | 1.40 Mn |
| Sep 30, 2020 | 1.47 Mn |
| Jun 30, 2020 | 907,000.00 |
| Mar 31, 2020 | 961,000.00 |